Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kang Shi

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
The Prostate|April 15, 2018
Quercetin protects against chronic prostatitis in rat model through NF-κB and MAPK signaling pathwaysLing-Quan Meng, Fei-Ya Yang, Ming-Shuai Wang, et al.
Journal of Applied Clinical Medical Physics|November 29, 2024
CT-based whole lung radiomics nomogram to identify middle-aged and elderly COVID-19 patients at high risk of progressing to critical diseaseXin'ang Jiang, Jun Hu, Qinling Jiang, et al.
European Journal of Medicinal Chemistry|April 6, 2017
Synthesis and evaluation of adenosine containing 3-arylfuran-2(5H)-ones as tyrosyl-tRNA synthetase inhibitorsWei Wei, Qi Liu, Zhen-Zhen Li, et al.
Journal of Medicinal Chemistry|March 23, 2012
Discovery and extensive in vitro evaluations of NK-HDAC-1: a chiral histone deacetylase inhibitor as a promising leadJingli Hou, Zhonghua Li, Qinghong Fang, et al.
BMJ Open|December 7, 2013
Evaluation of three-dose fosfomycin tromethamine in the treatment of patients with urinary tract infections: an uncontrolled, open-label, multicentre studyLu-Dong Qiao, Bo Zheng, Shan Chen, et al.
International Immunopharmacology|December 29, 2025
IMB16-5 alleviates liver fibrosis by targeting MICALL2/β-catenin signalingMao-Xu Ge, Dong Liu, Ting-Chao Liu, et al.
Medcomm|June 18, 2026
A Phase II Trial of Perioperative Camrelizumab Plus Neoadjuvant Chemotherapy in Resectable Stage IIB-IIIB Lung Squamous Cell CarcinomaMingming Hu, Shuku Liu, Yi Han, et al.
Bioorganic & Medicinal Chemistry|June 27, 2015
Synthesis and evaluation of N-analogs of 1,2-diarylethane as Helicobacter pylori urease inhibitorsZhu-Ping Xiao, Wei-Kang Shi, Peng-Fei Wang, et al.
Cancer Chemotherapy and Pharmacology|September 15, 2010
The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancerYi-kang Shi, Zhong-hua Li, Xi-qian Han, et al.
BMJ Open|December 17, 2013
Characteristics of urinary tract infection pathogens and their in vitro susceptibility to antimicrobial agents in China: data from a multicenter studyLu-Dong Qiao, Shan Chen, Yong Yang, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
The Prostate|April 15, 2018
Quercetin protects against chronic prostatitis in rat model through NF-κB and MAPK signaling pathwaysLing-Quan Meng, Fei-Ya Yang, Ming-Shuai Wang, et al.
Journal of Applied Clinical Medical Physics|November 29, 2024
CT-based whole lung radiomics nomogram to identify middle-aged and elderly COVID-19 patients at high risk of progressing to critical diseaseXin'ang Jiang, Jun Hu, Qinling Jiang, et al.
European Journal of Medicinal Chemistry|April 6, 2017
Synthesis and evaluation of adenosine containing 3-arylfuran-2(5H)-ones as tyrosyl-tRNA synthetase inhibitorsWei Wei, Qi Liu, Zhen-Zhen Li, et al.
Journal of Medicinal Chemistry|March 23, 2012
Discovery and extensive in vitro evaluations of NK-HDAC-1: a chiral histone deacetylase inhibitor as a promising leadJingli Hou, Zhonghua Li, Qinghong Fang, et al.
BMJ Open|December 7, 2013
Evaluation of three-dose fosfomycin tromethamine in the treatment of patients with urinary tract infections: an uncontrolled, open-label, multicentre studyLu-Dong Qiao, Bo Zheng, Shan Chen, et al.
International Immunopharmacology|December 29, 2025
IMB16-5 alleviates liver fibrosis by targeting MICALL2/β-catenin signalingMao-Xu Ge, Dong Liu, Ting-Chao Liu, et al.
Medcomm|June 18, 2026
A Phase II Trial of Perioperative Camrelizumab Plus Neoadjuvant Chemotherapy in Resectable Stage IIB-IIIB Lung Squamous Cell CarcinomaMingming Hu, Shuku Liu, Yi Han, et al.
Bioorganic & Medicinal Chemistry|June 27, 2015
Synthesis and evaluation of N-analogs of 1,2-diarylethane as Helicobacter pylori urease inhibitorsZhu-Ping Xiao, Wei-Kang Shi, Peng-Fei Wang, et al.
Cancer Chemotherapy and Pharmacology|September 15, 2010
The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancerYi-kang Shi, Zhong-hua Li, Xi-qian Han, et al.
BMJ Open|December 17, 2013
Characteristics of urinary tract infection pathogens and their in vitro susceptibility to antimicrobial agents in China: data from a multicenter studyLu-Dong Qiao, Shan Chen, Yong Yang, et al.
Pageof 11